Applicant/Recipient COVID-19 Update History

• ​​​​​​​NOT-DK-21-054:  Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic

• NOT-OD-21-006 - Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

• NIH Implementation of OMB Memorandum M-20-26 "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"  - 6/25/2020
  • Update: Effective October 1, 2020, the flexibility for recipients to continue charging salaries and benefits to active NIH awards consistent with the recipients' policy of paying salaries (under unexpected or extraordinary circumstances), has ended. Any requests after that date will be considered by the funding IC on a case by case basis.  As a reminder, recipients must maintain appropriate records and cost documentation in order to substantiate the charging of any salaries and other project activities costs related to interruption of operations or services. 

• Can a recipient continue to pay personnel costs under awards in the event of an emergency?
• Does the ability to charge personnel costs to NIH awards when no work is being performed also apply to summer salaries?
• If faculty at my institution are diverted from research to clinical work to care for COVID-19 patients, can the institution continue to charge their salary to an NIH grant?
• For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.

• My institution received an approved waiver from OLAW to postpone conducting semiannual animal facility inspections due to COVID-19. When does this waiver expire and when must we resume conducting the inspections?

• NOT-OD-20-173: Notice of Limited Availability of Research Non-human Primates

• NOT-OD-20-172: Reminder: NIH Natural Disaster Policy – Hurricane Laura
• NOT-OD-20-161: Reminder: NIH Natural Disaster Policy – Hurricane Isaias, Derecho

• NOT-OD-20-158: Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic

• Coronavirus Update: Additional Guidance for NIH Peer Reviewers (Summer 2020 Meetings/August-October 2020 Council) – June 9, 2020    

• NOT-MH-20-073: Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations

• If animals are currently in the vivarium but experiments have not started yet - can the animals be kept temporarily on a holding protocol (per diem charges still to the grant) until animals are used at the later postponed date?
• If investigators halt animal work due to the pandemic, preventing congruency with the approved protocol timeline, what is required of the investigators or the IACUC? Is it acceptable to issue a blanket statement allowing investigators to alter timelines, rather than requiring each PI to ament their study?

• Overview presentation (PowerPoint)
• Overview talking points (Word)

• Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic - NOT-OD-20-122

• Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-082)
• Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)” ) (NOT-AI-20-058)

• All COVID-19 FAQs were reviewed and revised to align with NIH Implementation of OMB Memorandum M-20-26.  "New" and "Updated" flags added to individual FAQs as needed.

• Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVID–related Disruptions - NOT-NS-20-076

• Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) (PAR-20-243)
• Notice of Correction to NOT-OD-20-119, NOT-OD-20-120, NOT-OD-20-121 Eligibility Section (NOT-OD-20-138)
• Notice of Correction to NOT-OD-20-120 Eligibility Section for Budget Request Information (NOT-OD-20-141)

• NIH Implementation of OMB Memorandum M-20-26 "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project (NOT-OD-20-129)
• Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers (NOT-CA-20-077)

• Notice of Pre-Application Webinar for the RADx-UP Initiative (NOT-OD-20-131)
• Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) (PAR-20-237)

• Overview presentation (PowerPoint)
• Overview talking points (Word)

• Application Submission
  • Updated: Will NIH accept late applications for new awards from applicants affected by COVID-19?
  • Removed outdated late policy FAQs

• Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need (NOT-TR-20-029)
• NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) (PAR-20-234)
• Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-121)
• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-120)
• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-119)
• Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) (RFA-OD-20-013)

• Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic - NOT-OD-20-123

• Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)" - NOT-HD-20-017

• Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (NOT-MH-20-053)
• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations (NOT-MD-20-022)
• Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) (RFA-CA-20-039)
• Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) (RFA-CA-20-038)
• Update to NOT-OD-20-107 - Notice of Change in Application Due Date for NOT-OD-20-107 "Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for COVID-19 – related Research" (NOT-OD-20-117)

• Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)
• Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) (NOT-MH-20-058)
   

• Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) (NOT-MD-20-023)

• Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives (NOT-OD-20-112)

• Added link to website for FDA application that allows investigators to obtain electronic informed consent

• Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) – related Research (NOT-OD-20-107)
• Update to NOT-NS-20-051: Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" (NOT-NS-20-074)

• Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012)

• Notice of Change: Late Application Policy for June 17, 2020, Application Due Date of PAR-19-242, Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Due to Public Health Emergency for US Coronavirus Disease 2019 - NOT-CA-20-069
• Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) - NOT-EB-20-012
• NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July - NOT-HG-20-041

• NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) (RFA-RM-20-021)
• NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) (RFA-RM-20-020)

• Overview presentation (Powerpoint)
• Overview talking points (Word)

• Financial and Performance Reporting (RPPR)
  • How should recipients submit details on how COVID-19 has delayed or affected the progress of research activities on NIH-funded grant projects?
• Foreign Components
  • If a post-doc on an active NIH grant must return home, to a foreign country, and work remotely due to COVID-19, must this be reported to NIH as a foreign component?
• Costs - Salary/Stipend Costs
  • For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.
  • If institutional funds are not available, can recipients affected by COVID-19 supplement NRSA stipends with funds from other federal awards?
• Training, Fellowship and Career Development
  • Can an international student who is unable to physically arrive in the U.S. to start their program this fall because of COVID-related travel restrictions, but who is participating in on-line distance education, be supported from federal grants? Can tuition be charged to the grant on which the faculty member intends for them to work when they arrive in the U.S.?
  • Can international students and post-docs continue to be supported on NIH grant projects if they are not able to return to the U.S. because of COVID-19 related travel restrictions?
  • Is NIH providing any COVID-19 related flexibilities to post-doctorates who’ve received Kirschstein-NRSA support and have payback obligations?

• NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) NOT-HD-20-016
• NIGMS Late Application Policy for NIGMS-Specific FOAs with Application Due Dates in May 2020 - NOT-GM-20-029
• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091

• Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-051)
• Update to NOT-AI-20-031: Notice of Early Expiration of “Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)"

• Late Application Policy for May 25, 2020, Application Due Date of NCI's Cancer Research Education Grants Program (R25) Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 Due to Public Health Emergency for US Coronavirus Disease 2019 - NOT-CA-20-068 under Proposal Submission & Award Management 

• Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence (NOT-CA-20-066)

• NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) - NOT-OD-20-105
  • T32 and T35 training grant applications submitted to the parent funding opportunity announcements PA-20-142 and PA-20-162 with a due date of May 25 will be accepted through June 30, 2020.

• Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" (NOT-OD-20-103)

• Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network (NOT-DE-20-023)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR (NOT-DE-20-022)

• NIH Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19 (released 4/29/2020)
  • Project proposals accepted through online RADx portal

• General
  • Is NIH providing flexibility on the requirements related to the use of Human Fetal Tissue (HFT) in NIH-funded research, in response to the public health emergency?
  • Where can I find information on NIH-funded trials and studies involving COVID-19?
  • What controls, if any, has NIH established for managing funding and activities related to the COVID-19 response? How will NIH management balance the need to implement the program quickly and maintain strong internal controls and manage the associated risks?
• Application Submission
  • What guidance are reviewers being given as they consider applications during the COVID-19 pandemic?
  • What should I do if I don’t have enough preliminary data for my application?
  • Do applicants have to apply for supplemental funds from the same IC that funded the parent grant?
  • What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?
• Financial and Performance Reporting
  • Is NIH providing flexibility to S10 recipients, who may be unable to submit on-time Annual Usage Reports, or unable to fulfill institutional usage commitments?
• Costs - Salary/Stipend Costs
  • Can a recipient continue to pay personnel costs under awards in the event of an emergency?
  • Does the ability to charge personnel costs to NIH awards when no work is being performed also apply to summer salaries?
  • For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.
• Costs - Prior Approvals
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
• Human Subjects
  • Is NIH providing flexibility to recipients for late results reporting in ClinicalTrails.gov due to COVID-19?
• Training, Fellowship and Career Development
  • Given the current COVID-19 situation resulting in office closures, are fellows still required to mail Individual Fellowship Activation Notice forms containing original signatures or are emailed forms with electronic or typed signatures adequate?
  • For phased awards such as the K22 and K99/R00, where recipients are not able to transition due to COVID-19, will NIH consider extensions for obtaining faculty positions?
  • Are childcare costs allowable charges to grants? Can they be charged for both PIs and for trainees for childcare costs need? Is this a usual allowable cost or a flexibility during the COVID pandemics?

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051)
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) (PAR-20-177)
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) (PAR-20-178)
• Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis (NOT-CA-20-054)

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs (NOT-TR-20-028)

• Overview presentation (Powerpoint)
• Overview talking points (Word) 

• NOT-AG-20-022
  • April 21, 2020 Update (NOT-AG-20-031): Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• NOT-DC-20-004
  • April 20, 2020 Update (NOT-DC-20-006): Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19

• OHRP COVID-19 Resources
• Live Videocast on Tuesday, April 28 from 1-2pm ET

• Animal Welfare
  • How may the IACUC extend a protocol that is due to expire and still meet the PHS Policy requirements?

• Application Submission
•  Is NIH providing flexibility for the required registrations for organizations to submit an application to NIH?
• Human Subjects
• My study was delayed during the COVID-19 public health emergency and I will not finish my project by the CoC expiration date. Can I get an extension on my CoC?
• ​​​Training, Fellowship, and Career Development Awards
• For non-phased K awards (K01, K08, K23, K25) will NIH permit requests for continued support or extensions due to COVID-19?
• If a T35 program is shortened, will the trainees’ stipend be decreased?
• Are institutions obligated to pay students if they have recruited them to a short-term T35 training program, but the training program was cancelled before it started?
• Can recipients change the originally proposed format of a T35 program by devising an electronic curriculum rather than in-person experiences?
• Can recipients shorten a T35 program, from 3 months to shorter periods (e.g. July and August)?
• Can recipients cancel the T35 program for this summer due to COVID issues?
• If a T35 program is shortened or cancelled can the unused funds carryover to the following year?
• What should K awardees do if they need to stop all research activities in order to provide clinical care (to COVID19 patients)?
• How will carryover for institutional training grants (e.g. T35, T32, K12) be handled?

• New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool

• Notice of Special Interest:  Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (NOT-AA-20-011)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-LM-20-010)

• Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 (NOT-NS-20-046)

• Supporting Yourself and Your Trainees During the Coronavirus Pandemic Online Workshops
• NIH Office of Intramural Training & Education: Virtual NIH Activities for Trainees Outside the NIH

• Removed OLAW webinar link; OLAW resources are maintained at COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs

• General
  • Do the flexibilities outlined in the recent guide notices and these FAQs apply to contracts, in addition to grants and cooperative agreements?
• Application Submission
  • What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?
  • Does the late application policy outlined in NOT-OD-20-091 apply to continuous submission deadlines?
  • Will NIH accept late submissions of reference letters?
  • NIH has stated that it will accept late applications for due dates from March 9, 2020 through May 1, 2020. If my institution has already submitted an application, can it be withdrawn? Can it be resubmitted during this period of flexibility?
• Financial and Performance Reporting
  • How should recipients notify NIH that closeout reports will be late?
• Foreign Components (new category)
  • If a post-doc on an active NIH grant must return home to a foreign country and work remotely due to COVID-19, must this be reported to NIH as a foreign component?
• Costs - Salary/Stipend Costs
  • Can a recipient continue to pay personnel costs under awards in the event of an emergency?
  • If faculty at my institution are diverted from research to clinical work to care for COVID-19 patients, can the institution continue to charge their salary to an NIH grant?
• Costs - Prior Approvals
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
  • Our institution has closed the lab for all but maintenance activities at this time. While we understand that charges for salaries, animal care, and other expenses may be allowable during this closure, will additional funds (e.g. from administrative supplements) be made available to support the lost time?
  • Is prior approval required if my institution plans to divert staff from research to clinical work to care for COVID-19 patients or to work on COVID-19 research activities?
• Costs - Other Costs (new sub-category)
  • Since most investigators are teleworking, can institutions now purchase laptops, desktops and other equipment using grant funds, to aid in telework?
• Human Subjects
  • Is NIH offering COVID-19-related flexibilities for updating and correcting study information in ClinicalTrials.gov?
• Training, Fellowship and Career Development
  • For phased awards (e.g. K22, K99, etc.) or other training, fellowship and career development awards where extensions are typically limited, will NIH consider extensions due to COVID-19?
  • For phased awards such as the K22 and K99/R00, where recipients are not able to transition due to COVID-19, will NIH consider extensions for obtaining faculty positions?
  • Can I request an extension for a Ruth L. Kirschstein National Research Service Award (NRSA) and/or fellowship award?
  • Will there be a single NIH-wide policy to cancel, shorten the duration, or create alternate (e.g., remote) training opportunities for summer T35 programs?
  • If a T32/T35 is cancelled or shortened, or is unable to fill all slots because of COVID-19, what will happen to the unused funds?

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (NOT-OD-20-097)

• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-020)
• Notice of Early Expiration of NOT-ES-20-015, "Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-019)
• Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)" (NOT-ES-20-016)
• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-008)
• Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-007)
• Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-006)
• Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-011)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) (CA-20-042)

New notice on Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission (NOT-DK-20-020)
• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (NOT-MD-20-019)
• Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-017)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NOT-MH-20-047)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-016)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-043)
• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-015)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NOT-DK-20-018)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-DC-20-004)
• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-759)

• Overview presentation (Powerpoint) - updated on April 21, 2020 
• Overview talking points (Word) - updated on April 21,  2020

• Added link to COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs

• Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

• Contracts must be handled on a case by case basis. Details regarding any contract must be directed to the cognizant Contracting Officer. Salary changes must be handled by the contracting officer.

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-HG-20-030)

• Substantial additions to Animal Welfare FAQs
• Prior Approval
  • Can recipients that are not covered under Streamlined Non-competing Application Process (SNAP) carry forward unobligated balances on their active awards that are affected by COVID-19?
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
• Training, Fellowship and Career Development Awards
  • Can a K99 applicant apply for an extension of the 4-year eligibility window (for initial applications or resubmissions) due to COVID-19? 

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (NOT-AI-20-030)
• Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (NOT-ES-20-014)
• Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)  ​(NOT-TR-20-012)

• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091 

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)
• Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need (NOT-R-20-111)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025)

• Substantial updates to FAQs including new section on Training, Fellowship and Career Development Awards

• Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need (NOT-TR-20-011)

• OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)

• Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 - NOT-OD-20-088
   

• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757)

• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087

• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

• NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-082 (Updated March 26 - NOT-OD-20-091)